Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa

NCT00677833 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00677833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00677833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2008
Completion date
September 30, 2010
Enrollment
361 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, falciparum